Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 1.2 Form of Underwriter's Warrant Agreement
- 1.3 Form of Public a Warrant Agreeemnt
- 1.4 Form of Public B Warrant Agreement
- 2.1 Agreement and Plan of Merger, Dated September 16, Among Medovex Corp. F/k/a Spinez Corp. and Debrider Inc.
- 3.1 Articles of Incorporation of Spinez Corp.
- 3.2 Certificate of Amendment to the Articles of Incorporation of Spinez Corp. (Changing the Name of the Company to Medovex Corp. and Effecting the Reverse Split of the Outstanding Shares of Medovex Corp.?s Common Stock)
- 3.3 Bylaws of Medovex Corp.
- 5.1 Opinion of Sichenzia Ross Friedman Ference LLP.
- 10.1 2013 Stock Incentive Plan.
- 10.2 Employment Agreement Between Medovex Corp. and Jarrett Gorlin Dated October 14, 2013.
- 10.3 Employment Agreement Between Medovex Corp. and Patrick Kullmann Dated October 14, 2013.
- 10.4 Employment Agreement Between Medovex Corp. and Charlie Farrahar Dated October 14, 2013.
- 10.5 Employment Agreement Between Medovex Corp. and Dennis Moon Dated November 11, 2013.
- 10.6 Contribution and Royalty Agreement Between Medovex and Scott W. Haufe, Dated January 31, 2013.
- 10.7 Co-development Agreement Between Medovex Corp. and DR. James Andrews Dated September 30, 2013.
- 10.8 Consulting Agreement Between Medovex Corp. and Robb Knie Dated December 2, 2013.
- 10.9 Engineering Services Agreement Between Medovex Corp. and Devicix, LLC Dated November 25, 2013.
- 21 Subsidiaries of Medovex Corp.
- 23.1 Consent of Marcum, LLP.
IVRN similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Medovex Corp. and Subsidiary on Form S-1 of our report dated May 1, 2014 except for Notes 2 and 9, and paragraph 2 of Note 6, as to which the date is September 5, 2014, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern and an emphasis of matter paragraph related to a restatement of the consolidated financial statements, with respect to our audit of the consolidated financial statements of Medovex Corporation and Subsidiary as of December 31, 2013 and consolidated statements of operations, changes in stockholders’ equity and cash flows for the period from February 1, 2013 (inception) to December 31, 2013, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading "Experts" in such Prospectus.
/s/ Marcum LLP
Marcum LLP
New York, NY
September 5th 2014